These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 23154111)

  • 1. [Aspirin for secondary prevention of venous thromboembolism. WARFASA: far from being conclusive].
    Delluc A; Lacut K; Mottier D
    Rev Med Interne; 2013 Feb; 34(2):69-72. PubMed ID: 23154111
    [No Abstract]   [Full Text] [Related]  

  • 2. Aspirin for the prevention of recurrent venous thromboembolism: the INSPIRE collaboration.
    Simes J; Becattini C; Agnelli G; Eikelboom JW; Kirby AC; Mister R; Prandoni P; Brighton TA;
    Circulation; 2014 Sep; 130(13):1062-71. PubMed ID: 25156992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspirin for prevention and treatment of venous thromboembolism.
    Becattini C; Agnelli G
    Blood Rev; 2014 May; 28(3):103-8. PubMed ID: 24745726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspirin and recurrent venous thromboembolism.
    Prandoni P; Noventa F; Milan M
    Phlebology; 2013 Mar; 28 Suppl 1():99-104. PubMed ID: 23482543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does the combination of warfarin and aspirin have a place in secondary stroke prevention? No.
    Fisher M
    Stroke; 2009 May; 40(5):1944-5. PubMed ID: 19299634
    [No Abstract]   [Full Text] [Related]  

  • 6. Aspirin for preventing the recurrence of venous thromboembolism.
    Becattini C; Agnelli G; Schenone A; Eichinger S; Bucherini E; Silingardi M; Bianchi M; Moia M; Ageno W; Vandelli MR; Grandone E; Prandoni P;
    N Engl J Med; 2012 May; 366(21):1959-67. PubMed ID: 22621626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Case-fatality of recurrent venous thromboembolism and major bleeding associated with aspirin, warfarin, and direct oral anticoagulants for secondary prevention.
    Wu C; Alotaibi GS; Alsaleh K; Linkins LA; McMurtry MS
    Thromb Res; 2015 Feb; 135(2):243-8. PubMed ID: 25488466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of deep vein thrombosis. First choice treatments.
    Prescrire Int; 2015 Sep; 24(163):217-9. PubMed ID: 26417635
    [No Abstract]   [Full Text] [Related]  

  • 9. Venous thromboembolism: "... an ounce of prevention is worth a pound of cure".
    Goldhaber SZ; Ageno W
    Thromb Haemost; 2015 Jun; 113(6):1174-5. PubMed ID: 25947622
    [No Abstract]   [Full Text] [Related]  

  • 10. Aspirin in the secondary prevention of unprovoked thromboembolism: the WARFASA and ASPIRE studies.
    Birocchi S; Scannella E; Ferrari L; Podda GM;
    Intern Emerg Med; 2013 Dec; 8(8):757-60. PubMed ID: 23744554
    [No Abstract]   [Full Text] [Related]  

  • 11. Warfarin therapy in patients with venous thromboembolism: patterns of use and predictors of clinical outcomes.
    Deitelzweig SB; Lin J; Kreilick C; Hussein M; Battleman D
    Adv Ther; 2010 Sep; 27(9):623-33. PubMed ID: 20680533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspirin for prevention of venous thromboembolism in recipients of major lower-limb orthopedic surgery: a systematic review of Level I evidence.
    Seagrave KG; Fletcher JP; Hitos K
    Int Angiol; 2019 Dec; 38(6):429-442. PubMed ID: 31580039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative efficacy and safety of anticoagulants and aspirin for extended treatment of venous thromboembolism: A network meta-analysis.
    Sobieraj DM; Coleman CI; Pasupuleti V; Deshpande A; Kaw R; Hernandez AV
    Thromb Res; 2015 May; 135(5):888-96. PubMed ID: 25795564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deep venous thrombosis and pulmonary embolism. Part 2--Prevention of recurrences: warfarin or low-molecular-weight heparin for at least 3 months.
    Prescrire Int; 2013 May; 22(138):129-33. PubMed ID: 23819181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does aspirin prevent venous thromboembolism?
    Diep R; Garcia D
    Hematology Am Soc Hematol Educ Program; 2020 Dec; 2020(1):634-641. PubMed ID: 33275727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Duration of anticoagulation: the decision-making process.
    Thompson R; Thachil J
    Br J Hosp Med (Lond); 2015 Oct; 76(10):C156-60. PubMed ID: 26457953
    [No Abstract]   [Full Text] [Related]  

  • 17. The prevention of venous thromboembolism recurrence in the elderly: a still open issue.
    Palareti G; Poli D
    Expert Rev Hematol; 2018 Nov; 11(11):903-909. PubMed ID: 30257119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of aspirin and low-molecular-weight heparin on venous thromboembolism after knee replacement: a non-randomised comparison using National Joint Registry Data.
    Jameson SS; Baker PN; Charman SC; Deehan DJ; Reed MR; Gregg PJ; Van der Meulen JH
    J Bone Joint Surg Br; 2012 Jul; 94(7):914-8. PubMed ID: 22733945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical inquiries. Does combining aspirin and warfarin decrease the risk of stroke for patients with nonvalvular atrial fibrillation?
    Robertson SL; Mayer JB; Guthmann R
    J Fam Pract; 2004 Jul; 53(7):570-5. PubMed ID: 15251100
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of aspirin and low-molecular-weight heparin on venous thromboembolism after hip replacement: a non-randomised comparison from information in the National Joint Registry.
    Jameson SS; Charman SC; Gregg PJ; Reed MR; van der Meulen JH
    J Bone Joint Surg Br; 2011 Nov; 93(11):1465-70. PubMed ID: 22058295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.